However, given the crucial role of antitumoral immune responses by CD8+ T cells in CLL (55), we focused on characterizing how the phenotype of CD8+ T cells changed when antibiotics were used for gut microflora ablation. This evidence concerns the gene CD8A and B-cell chronic lymphocytic leukemia.